Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jarkko P Hytönen"'
Autor:
Jarkko P Hytönen, Olli Leppänen, Jouni Taavitsainen, Petra Korpisalo, Svetlana Laidinen, Kari Alitalo, Jonas Wadström, Tuomas T Rissanen, Seppo Ylä-Herttuala
Publikováno v:
Vascular Biology, Vol 1, Iss 1, Pp 1-9 (2019)
Background: Prosthetic vascular grafts in humans characteristically lack confluent endothelialization regardless of the duration of implantation. Use of high-porosity grafts has been proposed as a way to induce endothelialization through transgraft c
Externí odkaz:
https://doaj.org/article/543a83924cf445bebaf14dec4ccf2d91
Autor:
Seppo Ylä-Herttuala, Jarkko P. Hytönen
Publikováno v:
Journal of visualized experiments : JoVE. (186)
Coronary artery disease is a major contributor to morbidity and mortality worldwide. While lifestyle changes and medication are the cornerstones of treatment, coronary artery balloon angioplasty and stenting are routinely performed on patients with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca44399f703ab46c3ab2b829f55efb8
https://pubmed.ncbi.nlm.nih.gov/36094257
https://pubmed.ncbi.nlm.nih.gov/36094257
Autor:
Seppo Ylä-Herttuala, Ply Chichareon, Hidenori Komiyama, Jarkko P. Hytönen, Rodrigo Modolo, Yosuke Miyazaki, Jouni Taavitsainen, Jan J. Piek, Yoshinobu Onuma, Kuniaki Takahashi, Andreas Baumbach, Erhan Tenekecioglu, Anthony Mathur, Joanna J. Wykrzykowska, Yohei Sotomi, Taku Asano, John Martin, Yuki Katagiri, Patrick W. Serruys, Norihiro Kogame
Publikováno v:
Circulation journal, 83(3), 556-566. Japanese Circulation Society
Circulation Journal, 83(3), 556-+. Japanese Circulation Society
Circulation Journal, 83(3), 556-+. Japanese Circulation Society
Background: Little is known about serial changes in lumen and device dimensions after bioresorbable scaffold implantation in a growing animal model. Methods and Results: ABSORB (n=14) or bare metal stents (ICROS amg [Abbott Vascular, Santa Clara, CA,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51e52dffd44487559d72055ec7d691d9
https://doi.org/10.1253/circj.cj-18-0855
https://doi.org/10.1253/circj.cj-18-0855
Autor:
Jouni Taavitsainen, Jarkko P. Hytönen, Svetlana Laidinen, Jonas Wadström, Kari Alitalo, Olli Leppänen, Petra Korpisalo, Seppo Ylä-Herttuala, Tuomas T. Rissanen
Publikováno v:
Vascular Biology, Vol 1, Iss 1, Pp 1-9 (2019)
Vascular Biology
Vascular Biology
Background Prosthetic vascular grafts in humans characteristically lack confluent endothelialization regardless of the duration of implantation. Use of high-porosity grafts has been proposed as a way to induce endothelialization through transgraft ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720dd4a5df31f9c5456b543aeba1f71e
https://vb.bioscientifica.com/view/journals/vb/1/1/VB-18-0001.xml
https://vb.bioscientifica.com/view/journals/vb/1/1/VB-18-0001.xml
Autor:
Jarkko P. Hytönen, Santeri Tarvainen, Manfred Guelcher, Eric K Mangiardi, Antti Kuivanen, Jouni Taavitsainen, John Martin, Seppo Ylä-Herttuala, Anthony Mathur
Publikováno v:
Journal of vascular research. 57(2)
Aims: Percutaneous coronary intervention is routinely performed to treat occlusive coronary artery disease. Coronary perforation is a potential complication and can be treated with a stent graft. Current stent grafts are associated with high restenos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc20771b479e39c47fec29548c40959a
https://pubmed.ncbi.nlm.nih.gov/32036370
https://pubmed.ncbi.nlm.nih.gov/32036370
Autor:
Wolf-Hagen Schunck, Michael von Bergwelt-Baildon, Martin Jastroch, Florian Blaschke, Jarkko P. Hytönen, Seppo Ylä-Herttuala, Burkert Pieske, Olli Leppänen, C. Mrowietz, Jörg-Detlef Drenckhahn, Ludwig Thierfelder, Kai Kappert, Friedrich Jung, Jan Hinrich Braesen, Dominik N Mueller, Arnd Heuser
Publikováno v:
Arterioscler. Thromb. Vasc. Biol. 36, 1534-1548 (2016)
Objective— Drug-eluting coronary stents reduce restenosis rate and late lumen loss compared with bare-metal stents; however, drug-eluting coronary stents may delay vascular healing and increase late stent thrombosis. The peroxisome proliferator–a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a98a20bd12ab2cbeb84401d71fc5a6
https://doi.org/10.1161/atvbaha.115.306962
https://doi.org/10.1161/atvbaha.115.306962
Autor:
Kari Alitalo, Jouni Taavitsainen, Anna Partanen, Seppo Ylä-Herttuala, Olli Leppänen, Johannes T.T. Laitinen, Jarkko P. Hytönen
Publikováno v:
Journal of molecular and cellular cardiology. 121
Background: Antiproliferative drugs in drug eluting stents (DES) are associated with complications due to impaired re-endothelialization. Additionally, adventitial neovascularization has been suggested to contribute to in-stent restenosis (ISR). Sinc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac3fe13c33afc865ce574b861acb808
https://pubmed.ncbi.nlm.nih.gov/30003882
https://pubmed.ncbi.nlm.nih.gov/30003882
Autor:
Eric Song, Anthony Mathur, Jouni Taavitsainen, Tarek M. Fahmy, Jarkko P. Hytönen, Martin John Francis, Hongshin Lee, Albert J. Sinusas, Kumar Perampaladas, Seppo Ylä-Herttuala, Manfred Gülcher, Dongin Kim, M. Labowsky, Jung Seok Lee, Patrick Han
Publikováno v:
Nano letters. 18(1)
The insertion of a stent in diseased arteries is a common endovascular procedure that can be compromised by the development of short- and long-term inflammatory responses leading to restenosis and thrombosis, respectively. While treatment with drugs,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d27b899a1bd1fde8946b16da81df83
https://pubmed.ncbi.nlm.nih.gov/29268605
https://pubmed.ncbi.nlm.nih.gov/29268605
Publikováno v:
Cardiovascular research. 114(8)
Angioplasty and stenting are standard treatment options for both stabile occlusive coronary artery disease and acute myocardial infarctions. Over the last years, several biodegradable stent systems have entered pre-clinical and clinical evaluation an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db006390fb09c2a75f8975613a999ae4
https://pubmed.ncbi.nlm.nih.gov/29718125
https://pubmed.ncbi.nlm.nih.gov/29718125
Autor:
Tuomas T. Rissanen, Seppo Ylä-Herttuala, Johannes T.T. Laitinen, Petra Korpisalo, Johanna Närväinen, Jarkko P. Hytönen, Olli Gröhn
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 307:H1226-H1232
Highly increased blood flow and vascularity after angiogenic gene therapy have raised concerns of shunting and hemangioma-like blood pool formation that might decrease effective perfusion and ruin the beneficial effects of the therapy. Contrast enhan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d59bb59ed9a055f013ebe7d3377ca0d
https://doi.org/10.1152/ajpheart.00315.2013
https://doi.org/10.1152/ajpheart.00315.2013